Search Results - "Yuen, Carrie"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Central and Peripheral Administration of Secretin Inhibits Food Intake in Mice through the Activation of the Melanocortin System by YUEN YEE CHENG, Carrie, YAN SHUEN CHU, Jessica, KWOK CHONG CHOW, Billy

    Published in Neuropsychopharmacology (New York, N.Y.) (01-01-2011)
    “…Secretin (Sct) is released into the circulation postprandially from the duodenal S-cells. The major functions of Sct originated from the gastrointestinal…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Type 2 innate lymphoid cells from Id1 transgenic mice alleviate skin manifestations of graft-versus-host disease by Srinivasan, Anand, Bajana, Sandra, Pankow, Aneta, Yuen, Carrie, Shah, Rikin K, Sun, Xiao-Hong

    Published in BMC immunology (13-07-2021)
    “…Acute graft-versus-host disease (aGVHD) is one of the most common causes of morbidity for patients undergoing allogeneic stem cell transplantation. There is…”
    Get full text
    Journal Article
  7. 7

    Azacitidine maintenance therapy post-allogeneic stem cell transplantation in poor-risk acute myeloid leukemia by Keruakous, Amany R., Holter-Chakrabarty, Jennifer, Schmidt, Sarah A., Khawandanah, Mohamad O., Selby, George, Yuen, Carrie

    Published in Hematology/oncology and stem cell therapy (01-03-2021)
    “…Allogeneic hematopoietic stem cell transplant (HSCT) is the potential curative modality for poor-risk acute myeloid leukemia (AML), relapse remains the main…”
    Get full text
    Journal Article
  8. 8

    Liposarcoma in children and young adults: A multi-institutional experience by Huh, Winston W., Yuen, Carrie, Munsell, Mark, Hayes-Jordan, Andrea, Lazar, Alexander J., Patel, Shreyaskumar, Wang, Wei-Lien, Barahmani, Nadia, Okcu, M. Fatih, Hicks, John, Debelenko, Larisa, Spunt, Sheri L.

    Published in Pediatric blood & cancer (15-12-2011)
    “…Background There are limited data regarding the differences in clinical presentation and outcome of liposarcomas between adult and pediatric patients. The role…”
    Get full text
    Journal Article
  9. 9

    Comparing 11 early warning scores and three shock indices in early sepsis prediction in the emergency department by Lam, Rex Pui Kin, Dai, Zonglin, Lau, Eric Ho Yin, Ip, Carrie Yuen Ting, Chan, Ho Ching, Zhao, Lingyun, Tsang, Tat Chi, Tsui, Matthew Sik Hon, Rainer, Timothy Hudson

    Published in World journal of emergency medicine (01-01-2024)
    “…This study aimed to evaluate the discriminatory performance of 11 vital sign-based early warning scores (EWSs) and three shock indices in early sepsis…”
    Get full text
    Journal Article
  10. 10

    Hemophagocytic Lymphohistiocytosis Secondary to Ehrlichia Chaffeensis in Adults: A Case Series From Oklahoma by Agudelo Higuita, Nelson Iván, Yuen, Carrie

    “…Hemophagocytic lymphohistiocytosis (HLH) is a syndrome of pathologic immune activation that occurs as either a familial disorder or as a sporadic condition in…”
    Get full text
    Journal Article
  11. 11

    Factors Affecting Natural Killer Cell Recovery after Autologous Stem Cell Transplantation in Multiple Myeloma by Keruakous, Amany R., Aljumaily, Raid, Zhao, Daniel, Asch, Adam S., Yuen, Carrie

    Published in Blood (23-11-2021)
    “…Introduction: Natural killer (NK) cells are large granular lymphocytes, very potent effector lymphocytes that can induce cytotoxicity against a vast array of…”
    Get full text
    Journal Article
  12. 12

    Prognostic impact of natural killer cell recovery on minimal residual disease after autologous stem cell transplantation in multiple myeloma by Keruakous, Amany R., Asch, Adam, Aljumaily, Raid, Zhao, Daniel, Yuen, Carrie

    Published in Transplant immunology (01-04-2022)
    “…Natural killer cells are a potent effector lymphocyte subset that can induce cytotoxicity without the need for antigen sensitization or presentation. NK cells…”
    Get full text
    Journal Article
  13. 13

    Predictors of response to upfront bortezomib, lenalidomide and dexamethasone (VRd) in multiple myeloma by Keruakous, Amany, Day, Silas, Borogovac, Azra, Holter, Jennifer L., Asch, Adam Steven, Yuen, Carrie

    Published in Journal of clinical oncology (20-05-2020)
    “…Abstract only e20507 Background: Achievement of response to less than very good partial response (VGPR) after initial induction is an adverse prognostic factor…”
    Get full text
    Journal Article
  14. 14

    Recovery of innate lymphoid cells after allogeneic stem cell transplant: A single institution pilot study by Srinivasan, Anand, Crawford, David, Bajana, Sandra, Yuen, Carrie, Sun, Xiao-Hong, Shah, Rikin

    Published in The Journal of immunology (1950) (01-05-2020)
    “…Abstract The response of Innate Lymphoid Cells (ILCs) to conditioning regimens and subsequent recovery in the setting of allogeneic hematopoietic stem cell…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    Hypomethylating Agent Maintenance Therapy after Allogeneic Stem Cell Transplant Improves Transplant Outcome in High Risk Acute Myelogenous Leukemia by Keruakous, Amany R., Holter Chakrabarty, Jennifer, Schmidt, Sarah Ann, Khawandanah, Mohamad O., Selby, George, Yuen, Carrie

    Published in Blood (13-11-2019)
    “…Background: Allogeneic hematopoietic stem cell transplant (HSCT) is the only potential curative modality for high risk acute myelogenous leukemia (AML)…”
    Get full text
    Journal Article
  18. 18

    Outcomes of Allogeneic Stem Cell Transplantation with Individualized Dosing of Antithymocyte Globulin by Keruakous, Amany R., Selby, George, Schmidt, Sarah A., Holter-Chakrabarty, Jennifer, Khawandanah, Mohamad O., Steward, Jennifer, Day, Silas, Yuen, Carrie

    Published in Blood (05-11-2020)
    “…Background: Allogeneic hematopoietic stem cell transplantation (HCT) is a potentially curative procedure for a variety of hematologic malignancies. However,…”
    Get full text
    Journal Article
  19. 19

    Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial by Mateos, Maria-Victoria, Schjesvold, Fredrik, Simpson, David, George, Anupkumar, Goldschmidt, Hartmut, Larocca, Alessandra, Chanan-Khan, Asher, Sherbenou, Daniel, Avivi, Irit, Benyamini, Noam, Matsumoto, Morio, Suzuki, Kenshi, Ribrag, Vincent, Usmani, Saad Z, Jagannath, Sundar, Ocio, Enrique M, Kher, Uma, Farooqui, Mohammed, Marinello, Patricia, Lonial, Sagar, Grigoriadis, George, Catalano, John, LeBlanc, Richard, Elemary, Mohamed, Bahlis, Nizar, Facon, Thierry, Karlin, Lionel, Ribrag, Vincent, Attal, Michel, Goldschmidt, Hartmut, Engelhardt, Monika, Weisel, Katja, Mackensen, Andreas, Nagler, Arnon, Ben Yehuda, Dina, Avivi, Irit, Benyamini, Noam, Magen-Nativ, Hila, Palumbo, Antonio, Cavo, Michele, Tobinai, Kensei, Suzuki, Kenshi, Kosugi, Hiroshi, Taniwaki, Masafumi, Sunami, Kazutaka, Matsumoto, Morio, Ando, Kiyoshi, Ganly, Peter, Blacklock, Hilary, Simpson, David, George, Anupkumar, Schjesvold, Fredrik, Lahuerta, Juan, Oriol Rocafiguera, Albert, Mateos, Maria, Rodriguez-Otero, Paula, Larson, Sarah, Atanackovic, Djordje, Devarakonda, Srinivas, Morganstein, Neil, Saylors, Gene, Oliff, Ira, Kirkel, Dean, Shtivelband, Mikhail, Yuen, Carrie, Yee, Andrew, Htut, Myo, Raza, Shahzad, Chhabra, Saurabh, Hari, Parameswaran, Bank, Bruce, Malek, Ehsan, Gasparetto, Cristina, Faroun, Ycaoub, Sherbenou, Daniel, Kreisle, William, Singhal, Seema, Rosenblatt, Jacalyn, Usmani, Saad, Lee, Wes, Safah, Hana, Lutzky, Jose, Pan, Dorothy, Baron, Ari, Manges, Robert, Steis, Ronald, Moreb, Jan, Callander, Natalie, Anz, Bertrand, Raptis, Anastasios, Stampleman, Laura, Melear, Jason, Boyd, Thomas, Garbo, Lawrence, Klein, Leonard, Shao, Spencer, Lyons, Roger, McIntyre, Kristi, Yasenchak, Christopher, Yimer, Habte

    Published in The Lancet. Haematology (01-09-2019)
    “…Pomalidomide and dexamethasone is a standard of care for patients with multiple myeloma in whom bortezomib and lenalidomide treatment has failed. KEYNOTE-183…”
    Get full text
    Journal Article
  20. 20